Related Experiment Video
Updated: Nov 30, 2025

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
Senescent T Cells as a Resistance Mechanism to Lung Cancer Immunotherapy
Diego Salas-Benito1, Iñaki Eguren-Santamaria1, Miguel F Sanmamed2,3,4,5
1Oncology Department, Clinic University of Navarra, Pamplona, Spain.
Abstract:
It has been reported that a group of patients with advanced non-small cell lung cancer showed circulating T cells with a senescent phenotype, and an abundance of such cells is associated with worse clinical response to immune checkpoint inhibitors. This study encourages further analysis of the role of senescent T cells in resistance to lung cancer immunotherapy.See related article by Ferrara et al., p. 492.
Related Concept Videos
Tumor Immunotherapy
Replicative Cell Senescence
Treatment Resistant Cancers
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cell-mediated Immune Responses

